Position in AVXL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$48,793
+$10,931 QoQ
Shares Held
18,839
+52.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 179 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $2,276,517 across 6 Biotechnology names. AVXL ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,999 | $992,963 | |
| 2 | TECH |
BIO-TECHNE Corp
|
7,581 | $535,597 | |
| 3 | INCY |
Incyte Corp
|
3,844 | $435,755 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
4,378 | $250,509 | |
| 5 | AVXL |
Anavex Life Sciences Corp.
This page
|
18,839 | $48,793 | |
| 6 | DRMA |
Dermata Therapeutics, Inc.
|
10,000 | $12,900 |
All Filings in AVXL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,793 | 18,839 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $37,862 | 12,333 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $43,905 | 12,333 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||